RMRP mutations in hematological disorders [1]

Clinical Genetics

Volumn 71, Issue 5, 2007, Pages 468-470

  Graf, S A ^a,b   Calado, R T ^a   Kajigaya, S ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GENE PRODUCT; GENOMIC DNA; RIBONUCLEASE MITOCHONDRIAL RNA PROCESSING PROTEIN; RNA 5.8S; UNCLASSIFIED DRUG;

ADULT; APLASTIC ANEMIA; ASIAN; CAUCASIAN; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA EXTRACTION; ETHNICITY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC DIFFERENCE; GENETIC RISK; GENETIC VARIABILITY; HEMATOLOGIC DISEASE; HETEROZYGOSITY; HISPANIC; HOMOZYGOSITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; NEGRO; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ANEMIA, APLASTIC; DNA MUTATIONAL ANALYSIS; ENDORIBONUCLEASES; FEMALE; GENE FREQUENCY; HUMANS; MALE; MUTATION;

EID: 34248326908     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00776.x     Document Type: Letter

References (14)

1. Ridanpaa M, van EH, Pelin K et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 2001: 104: 195-203.
2. McKusick VA, Eldridge R, Hostetler JA, Ruangwit U, Egeland JA. Dwarfism in the amish. II Cartilage-hair hypoplasia. Bull Johns Hopkins Hosp 1965: 116: 285-326.
3. Makitie O. Cartilage-hair hypoplasia in Finland: Epidemiological and genetic aspects of 107 patients. J Med Genet 1992: 29: 652-655.
4. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006: 108: 2511-2521.
5. Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford, 1991.
6. Packer BR, Yeager M, Staats B et al. SNP500Cancer: A public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004: 32: D528-D532.
7. Bonafe L, Schmitt K, Eich G, Giedion A, Superti-Furga A. RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphisms. Clin Genet 2002: 61: 146-151.
8. Hermanns P, Bertuch AA, Bertin TK et al. Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet 2005: 14: 3723-3740.
9. Hirose Y, Nakashima E, Ohashi H et al. Identification of novel RMRP mutations and specific founder haplotypes in Japanese patients with cartilage-hair hypoplasia. J Hum Genet 2006: 51: 706-710.
10. Thiel CT, Horn D, Zabel B et al. Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet 2005: 77: 795-806.
11. Hermanns P, Tran A, Munivez E et al. RMRP mutations in cartilage-hair hypoplasia. Am J Med Genet A 2006: 140: 2121-2130.
12. Bonafe L, Dermitzakis ET, Unger S et al. Evolutionary comparison provides evidence for pathogenicity of RMRP mutations. PloS Genet 2005: 1: E47.
13. Sellick GS, Catovsky D, Houlston RS. Familial chronic lymphocytic leukemia. Semin Oncol 2006: 33: 195-201.
14. Makitie O, Pukkala E, Teppo L, Kaitila I. Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr 1999: 134: 315-318.